Article (Scientific journals)
Le medicament du mois. Femoston Low (0,5 mg d'estradiol plus 2,5 mg de dydrogesterone) comme traitement hormonal de substitution a la menopause.
SCHEEN, André; Gaspard, Ulysse
2011In Revue Médicale de Liège, 66 (4), p. 209-14
Peer reviewed
 

Files


Full Text
8. SCHEEN Med Femoston (6).pdf
Publisher postprint (185.97 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Drug Combinations; Dydrogesterone/pharmacology; Estradiol/pharmacology; Estrogen Replacement Therapy; Female; Humans
Abstract :
[en] Femoston Low is a hormone replacement therapy that combines low dosages of steroids, i.e. 0.5 mg of estradiol and 2.5 mg of dydrogesterone. This oral preparation should be taken continuously to treat climacteric symptoms in menopausal women. Femoston Low is in agreement with the recent recommendations for menopausal hormone replacement therapy, which give the preference to low dosage therapy whenever possible. The goals are to potentially minimize the risk of breast cancer, the danger of venous or arterial thrombosis and the glucose and lipid metabolic disturbances. Nevertheless, the preparation should efficaciously oppose to endometrial hyperplasia and yield a high degree of amenorrhea.
Disciplines :
Pharmacy, pharmacology & toxicology
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
SCHEEN, André  ;  Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Gaspard, Ulysse ;  Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
Language :
French
Title :
Le medicament du mois. Femoston Low (0,5 mg d'estradiol plus 2,5 mg de dydrogesterone) comme traitement hormonal de substitution a la menopause.
Alternative titles :
[en] Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy
Publication date :
2011
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
66
Issue :
4
Pages :
209-14
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 01 October 2011

Statistics


Number of views
1410 (4 by ULiège)
Number of downloads
20691 (47 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi